Search

Displaying results 651 - 660 of 8695 in total
  1. Drug

    Hyaluronidase

    go.drugbank.com/drugs/DB14740
    ApprovedInvestigational

    [A199047] Hyaluronidase was first used in prescription products in the United States on 5 May 2004.[L13338] … [A199026] Hyaluronidase has been used in surgical settings for at least the past 60 years to improve the diffusion of local anesthetics.

    Products: HYALASE POWDER FOR INJECTION 1500 iu/ampoule, . - Pulver zur Herstellung einer Injektionslösung
  2. Drug

    Coffee bean

    go.drugbank.com/drugs/DB10525
    Approved

    Coffee bean allergenic extract is used in allergenic testing.

    Products: Coffee for Diagnostic Use Only
  3. Drug

    Strontium ranelate

    go.drugbank.com/drugs/DB09267
    ApprovedWithdrawn

    Available for prescription use for a time in some parts of the world as Protelos (strontium ranelate) 2 g granules for oral suspension by Servier, it was ultimately discontinued in 2016-2017 owing to an … Strontium ranelate, a strontium (II) salt of ranelic acid, is a medication for osteoporosis.

    Categories: Drugs for Treatment of Bone DiseasesProducts: PROTOS Granules for Oral Suspension 2g
  4. Drug

    LB54640

    go.drugbank.com/drugs/DB18331
    Investigational

    LB54640 is orally-administered small molecule agonist of the melanocortin 4 receptor.

    Synonyms: Oral melanocortin 4 receptor agonist, Small molecule melanocortin 4 receptor agonist
  5. Drug

    Interferon beta-1b

    go.drugbank.com/drugs/DB00068
    ApprovedInvestigational

    Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD

    Categories: Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme InhibitorsProducts: BETAFERON FOR INJECTION 0.25 mg/ml
  6. Drug

    Oxybutynin

    go.drugbank.com/drugs/DB01062
    ApprovedInvestigational

    [A185996,A185999] Oxybutynin, also marketed as Ditropan XL, is an anticholinergic medication used for the relief of overactive bladder symptoms that has been optimized for high levels of safety and … [A183782,L8648] This drug relieves undesirable urinary symptoms, increasing the quality of life for patients affected by OAB. It is often used as first-line therapy for OAB.[A185990]

    Categories: Drugs for Urinary Frequency and Incontinence, Cytochrome P-450 SubstratesProducts: Oxytrol For Women, Oxytrol for Women
  7. Drug

    Technetium Tc-99m albumin colloid

    go.drugbank.com/drugs/DB09447
    ApprovedWithdrawn

    Products: Pulmolite, Kit for the Preparation of Technetium Tc99m Albumin Aggregated
  8. Drug

    Dornase alfa

    go.drugbank.com/drugs/DB00003
    ApprovedInvestigational

    In individuals with cystic fibrosis, extracellular DNA, which is an extremely viscous anion, is released by degenerating leukocytes that accumulate during inflammatory responses to infections.

    Products: ./2,5 ml - Lösung für einen Vernebler
  9. Drug

    Dactinomycin

    go.drugbank.com/drugs/DB00970
    ApprovedInvestigational

    A compound composed of a two cyclic peptides attached to a phenoxazine that is derived from streptomyces parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termina...

    Categories: P-glycoprotein inhibitors, P-glycoprotein substratesProducts: DACTINOMYCIN FOR INJECTION 0.5 mg/vial
  10. Drug

    Pyrophosphoric acid

    go.drugbank.com/drugs/DB04160
    ApprovedInvestigational

    Products: TECHNESCAN PYP, KIT FOR RADIOPHARMACEUTICAL PREPARATION, 20MG/VIAL